Cent Eur J Public Health 2018, 26(2):83-86 | DOI: 10.21101/cejph.a4502

Hepatitis C testing among adults born between 1945 and 1965 in Turkey: a multicentre study

Mustafa Altındis1, Tayfur Demiray1, Mehmet Köroğlu1, Ali Rıza Atasoy1, Recep Keşli2, Selma Tosun3, Mehmet Özdemir4, Alper Aksözek5, Gülfem Ece6, Yeliz Çetinkol7, Selma Altındis8, Hüseyin Güdücüoğlu9
1 Department of Medical Microbiology, Faculty of Medicine, Sakarya University, Sakarya, Turkey
2 Department of Medical Microbiology, School of Medicine, Afyon Kocatepe University, Afyon, Turkey
3 Izmir Bozyaka Training and Research Hospital, Izmir, Turkey
4 Department of Medical Microbiology, School of Medicine, Necmettin Erbakan University, Konya, Turkey
5 Department of Medical Microbiology, School of Medicine, Mugla University, Mugla, Turkey
6 Medical Microbiology Laboratory, Medical Park Hospital, Izmir, Turkey
7 Department of Medical Microbiology, School of Medicine, Ordu University, Ordu, Turkey
8 Department of Healthcare Management, School of Management, Sakarya University, Sakarya Turkey
9 Department of Medical Microbiology, School of Medicine, Yuzuncu Yil University, Van, Turkey

Objective: Hepatitis C virus (HCV) infection is a major public health problem and affects large populations all over the world. Serum anti-HCV level is a valuable marker to determine HCV infection. Anti-HCV testing has been recommended for high-risk population. The Center for Disease Control (CDC) and Prevention in the United States proposed a new high-risk population group - adults born between 1945-1965. Under this perspective, we designed a multicentre retrospective study to determine the seropositivity of anti-HCV among adults born between 1945 and 1965 and adults born after 1965 in Turkey. With the data collected, we aimed to determine whether there was a need for anti-HCV testing especially in people born between 1945 and 1965.

Methods: We requested data from ten different medical centres in ten different provinces. Each medical centre collected the anti-HCV test results of adult patients for five-year period between 2009 and 2014 from hospital records.

Results: A total of 974,449 anti-HCV test results were included in this study. When the seropositivity rates in the two groups of adults were compared, anti-HCV seropositivity rates were higher in nine medical centres out of ten. Anti-HCV seropositivity in adults born between 1945-1965 was significantly higher than in adults born after 1965 (p < 0.05).

Conclusions: We determined that the anti-HCV seropositivity rate is significantly higher in adults born between 1945-1965 compared to the younger adults as indicated in the literature. According to data from this study together with the WHO and CDC suggestions, we believe that it is appropriate to offer anti-HCV serology testing for people over 50 years of age since the anti- HCV seroprevalence in this age group is relatively high.

Klíčová slova: anti-HCV, HCV seropositivity, HCV age group, elder population

Vloženo: 20. červenec 2015; Revidováno: 20. duben 2017; Přijato: 20. duben 2017; Zveřejněno: 30. červen 2018  Zobrazit citaci

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Altındis M, Demiray T, Köroğlu M, Atasoy AR, Keşli R, Tosun S, et al.. Hepatitis C testing among adults born between 1945 and 1965 in Turkey: a multicentre study. Cent Eur J Public Health. 2018;26(2):83-86. doi: 10.21101/cejph.a4502. PubMed PMID: 30102494.
Sdílet...
Stáhnout citaci
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Zobrazit celý článek

    Reference

    1. Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology. 2013 Apr;57(4):1333-42. Přejít k původnímu zdroji... Přejít na PubMed...
    2. Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol. 2006 Oct;45(4):529-38. Přejít k původnímu zdroji... Přejít na PubMed...
    3. Chou R, Cottrell EB, Wasson N, Rahman B, Guise JM. Screening for hepatitis C virus infection in adults: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2013 Jan 15;158(2):101-8. Přejít k původnímu zdroji... Přejít na PubMed...
    4. Gower E, Estes C, Blach S, Razavi-Shearer K, Razavi H. Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol. 2014 Nov;61(1 Suppl):S45-57. Přejít k původnímu zdroji... Přejít na PubMed...
    5. Inci M, Aksebzeci AT, Yagmur G, Kartal B, Emiroglu M, Erdem Y. Investigation of HBV, HCV and HIV seropositivity in healthcare workers. Turk Hij Deney Biyol Derg. 2009;66(2):59-66. (In Turkish.)
    6. Villena EZ. Transmission routes of the hepatitis C virus infection. Ann Hepatol. 2006;5(Suppl 1):S12-14. Přejít k původnímu zdroji...
    7. Centers for Disease Control and Prevention. Hepatitis C testing for anyone born during 1945-1965: New CDC recommendations [Internet]. Atlanta: CDC [cited 2015 Jun 30]. Available from: http://www.cdc.gov/features/HepatitisCTesting/.
    8. Yildirim M, Çakir S, Geyik MF, Özdemir D, Güçlü E, Çakir M. Seroprevalences and associated risk factors of hepatitis B and C in adults. Turk J Med Sci. 2014;44(5):824-31. Přejít k původnímu zdroji...
    9. Tozun N, Ozdogan OC, Cakaloglu Y, Idilman R, Karasu Z, Akarca UZ, et al. A nationwide prevalence study and risk factors for hepatitis A, B, C and D infections in Turkey. Hepatology. 2010;52(Suppl 1):697.
    10. Demirtürk N, Demirdal T, Toprak D, Altindiş M, Aktepe OC. Hepatitis B and C virus in West-Central Turkey: seroprevalence in healthy individuals admitted to a university hospital for routine health checks. Turk J Gastroenterol. 2006 Dec;17(4):267-72.
    11. Kalayci R, Altindiş M, Gülamber G, Demirtürk N, Akcan Y, Demirdal T. Genotype distribution of chronic hepatitis B and hepatitis C patients and investigation of the resistance patterns in hepatitis B cases. Mikrobiyol Bul. 2010 Apr;44(2):237-43. (In Turkish.) Přejít na PubMed...
    12. World Health Organization. Hepatitis [Internet]. Geneva: WHO [cited 2016 Apr 3]. Available from: http://www.who.int/csr/disease/hepatitis/whocdscsrlyo 2003/en/index4.html.
    13. Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med. 2006 May 16;144(10):705-14. Přejít k původnímu zdroji... Přejít na PubMed...
    14. Smith BD, Beckett GA, Yartel A, Holtzman D, Patel N, Ward JW. Previous exposure to HCV among persons born during 1945-1965: prevalence and predictors, United States, 1999-2008. Am J Public Health. 2014 Mar;104(3):474-81. Přejít k původnímu zdroji... Přejít na PubMed...
    15. Cartwright EJ, Rentsch C, Rimland D. Hepatitis C virus screening practices and seropositivity among US veterans born during 1945 - 1965. BMC Res Notes. 2014 Jul 14;7:449. doi: 10.1186/1756-0500-7-449. Přejít k původnímu zdroji... Přejít na PubMed...
    16. Pfeifer GM. Adults born between 1945 and 1965 need one-time hepatitis C testing. Am J Nurs. 2012 Nov;112(11):16. doi: 10.1097/01.NAJ.0000422242.11847.ad. Přejít k původnímu zdroji... Přejít na PubMed...
    17. Moyer VA; U.S. Preventive Services Task Force. Screening for hepatitis C virus infection in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2013 Sep 3;159(5):349-57. Přejít k původnímu zdroji... Přejít na PubMed...
    18. Aydemir O, Demiray T, Köroğlu M, Ciftci IH, Özbek A, Altindis M. Hepatitis C Prevalence in Different Age Groups; People Over 50 Years of Age May Receive One-Time Testing for Anti-HCV. Viral Hepat J. 2015;21:40-3. Přejít k původnímu zdroji...

    Zpět na obsah